Scientific leadership focused on developing new strategies for the prevention of heart diseases

Woman wearing a blood pressure cuffGeorge Clinical has the breadth of expertise and clinical networks to make what is traditionally one of the most complex and time consuming therapeutic areas to conduct clinical trials, one of the most streamlined. George Clinical provides sponsors with a unique opportunity to engage with their investigator networks like never before.

Heart disease is the leading cause of death in the world. It accounts for more than 17 million deaths a year and that figure is rising.

George Clinical’s scientific leadership is primarily focussed on developing new strategies for the prevention of heart diseases by targeting their primary risk factors such as high blood pressure and cholesterol, through drug and device interventions.

The depth of George Clinical’s therapeutic expertise places us as global experts in designing and implementing studies measuring cardiovascular co-morbidities and outcomes to the highest scientific standard.

George Clinical’s scientific leadership have a formidable track record of providing evidence to effect real change in practice and policy so that our research translates into clinical practice and government policy.

Our clinical trial services in cardiovascular health include:

George Clinical’s global cardiovascular investigator networks are substantial. Our expertise and capacity to engage with Asian investigator networks, place us as one of the leading cardiovascular contract research organisations operating in this therapeutic area.

Twitter Facebook LinkedIn